NCT02017899View on ClinicalTrials.gov

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Shigellosis
Interventions
BIOLOGICAL

S. sonnei 1790GAHB

BIOLOGICAL

Placebo

Trial Locations (1)

75679

Centre d'Investigation Clinique en Vaccinologie Cochin-Pasteur (CIC1417), Paris

All Listed Sponsors
lead

GSK Vaccines Institute For Global Health S.r.l.

INDUSTRY

NCT02017899 - A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults. | Biotech Hunter | Biotech Hunter